These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 38825678)

  • 1. Neuroleptic malignant syndrome and serotonin syndrome: a comparative bibliometric analysis.
    Sweileh WM
    Orphanet J Rare Dis; 2024 Jun; 19(1):221. PubMed ID: 38825678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management.
    Perry PJ; Wilborn CA
    Ann Clin Psychiatry; 2012 May; 24(2):155-62. PubMed ID: 22563571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosing subtypes of neuroleptic malignant syndrome: an introduction to the Lee-Carroll Scale.
    Carroll BT; Lee JW; Graham KT; Thalassinos A; Thomas C; Kirkhart R
    Ann Clin Psychiatry; 2008; 20(1):47-8. PubMed ID: 18297586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome and serotonin syndrome in the critical care setting: case analysis.
    Kaufman KR; Levitt MJ; Schiltz JF; Sunderram J
    Ann Clin Psychiatry; 2006; 18(3):201-4. PubMed ID: 16923659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool.
    Sokoro AA; Zivot J; Ariano RE
    Ann Pharmacother; 2011 Sep; 45(9):e50. PubMed ID: 21878660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What clinical analysis of antipsychotic-induced catatonia and neuroleptic malignant syndrome tells us about the links between these two syndromes: A systematic review.
    Virolle J; Redon M; Montastruc F; Taïb S; Revet A; Zivkovic V; Da Costa J; Very E
    Schizophr Res; 2023 Dec; 262():184-200. PubMed ID: 37599139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic sclerosis associated respiratory involvement: Scopus-based analysis of articles in 2013-2022.
    Doskaliuk B; Kreminska I; Fedorchenko Y; Zaiats L; Yatsyshyn R
    Rheumatol Int; 2024 Apr; 44(4):693-702. PubMed ID: 38319374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic Malignant Syndrome: Diagnosis and Management.
    Ware MR; Feller DB; Hall KL
    Prim Care Companion CNS Disord; 2018 Jan; 20(1):. PubMed ID: 29325237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Genetic Foundations of Serotonin Syndrome, Neuroleptic Malignant Syndrome, and Malignant Hyperthermia: Is There a Genetic Association Between These Disorders?
    Ortiz JF; Wirth M; Eskander N; Cozar JC; Fatade O; Rathod B
    Cureus; 2020 Sep; 12(9):e10635. PubMed ID: 33123448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research hotspots and trends of nanomaterials in stomatology: A bibliometric analysis from 2000 to 2023.
    Liang L; Han Z; Yang R; Guo Y; Chen Z
    Heliyon; 2024 Mar; 10(6):e27967. PubMed ID: 38545160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between selective serotonin-reuptake inhibitors, second-generation antipsychotics, and neuroleptic malignant syndrome.
    Stevens DL
    Ann Pharmacother; 2008 Sep; 42(9):1290-7. PubMed ID: 18628446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin syndrome overlapping with neuroleptic malignant syndrome: A case report and approaches for differentially diagnosing the two syndromes.
    Nisijima K
    Asian J Psychiatr; 2015 Dec; 18():100-1. PubMed ID: 26506919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catatonia and Neuroleptic Malignant Syndrome in Patients With Cerebral Palsy: Two Case Reports and a Systematic Review of the Literature.
    Barnett BS; Balaji D; Weleff J; Carroll BT
    J Acad Consult Liaison Psychiatry; 2023; 64(3):277-293. PubMed ID: 36586471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bibliometric and visual analysis of cancer-associated fibroblasts.
    Yuan WC; Zhang JX; Chen HB; Yuan Y; Zhuang YP; Zhou HL; Li MH; Qiu WL; Zhou HG
    Front Immunol; 2023; 14():1323115. PubMed ID: 38173726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research Trends in the Application of Artificial Intelligence in Oncology: A Bibliometric and Network Visualization Study.
    Wu T; Duan Y; Zhang T; Tian W; Liu H; Deng Y
    Front Biosci (Landmark Ed); 2022 Aug; 27(9):254. PubMed ID: 36224012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging research themes in maternal hypothyroidism: a bibliometric exploration.
    Chen A; Luo Z; Zhang J; Cao X
    Front Immunol; 2024; 15():1370707. PubMed ID: 38596686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serotonin syndrome and malignant neuroleptic syndrome. A review based on the material from the National Board of Adverse Drug Reactions].
    von Halling Laier MG; Gram LF
    Ugeskr Laeger; 1996 Nov; 158(48):6933-7. PubMed ID: 8984761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The State of the Catatonia Literature: Employing Bibliometric Analysis of Articles From 1965-2020 to Identify Current Research Gaps.
    Weleff J; Barnett BS; Park DY; Akiki TJ; Aftab A
    J Acad Consult Liaison Psychiatry; 2023; 64(1):13-27. PubMed ID: 35840002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.